Google sign-in. No card required.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Vice President, Global Scientific Communications, Medical Information, Content and Education will lead scientific narrative, publication strategy, medical content and training, medical education across Revolution Medicines’ portfolio.
This leader will translate complex and evolving evidence into accurate, clear and clinically relevant scientific communications and medical information services. The role will establish an integrated approach across Global, Regional and Country Medical Affairs, ensuring healthcare professionals, patients, caregivers and other relevant stakeholders have access to timely, balanced and evidence-based information throughout the product lifecycle.
As a member of the Global Medical Affairs leadership team, the Vice President will build and lead a high-performing scientific organization, including Global Medical Information, and partner closely with therapeutic area leaders, Clinical Development, Research, Field Medical and Regional and Country Medical Affairs.
The role will work in close partnership with the Vice President, Global Medical Affairs, Engagement, Analytics & Impact, as well as other members of the Global Medical Affairs Leadership Team, connecting scientific content and medical information with stakeholder insights, enabling technology and impact measurement through clearly defined accountabilities.
Global Medical Information Leadership
-
Own the global strategy, operating model and delivery of Medical Information services across the portfolio.
-
Build and scale Global Medical Information to support geographic expansion, multiple launches and increasing inquiry volume and complexity.
-
Oversee timely, accurate, balanced and evidence-based responses to unsolicited inquiries from healthcare professionals, patients, caregivers and other stakeholders.
-
Lead the development and maintenance of standard scientific response documents, frequently asked questions and supporting reference resources.
-
Establish scientific and service standards for inquiry intake, triage, response, escalation, documentation and quality assurance.
-
Define global standards and regional and country responsibilities, enabling local adaptation to language, healthcare context and applicable requirements.
-
Oversee medical information service providers and contact centers, including scientific training, service quality, capacity and performance.
-
Ensure appropriate processes for identifying and routing adverse events, product complaints and other reportable information to accountable functions.
-
Establish medical information readiness for launches, new indications, major data releases and emerging scientific questions.
-
Partner with Pharmacovigilance, Quality, Regulatory Affairs, Legal and Compliance on processes supporting safe and appropriate information exchange.
Scientific Narrative and Communication Strategy
-
Lead the development and evolution of portfolio and asset-level scientific narratives in partnership with therapeutic area leaders and evidence-generating functions.
-
Ensure narratives reflect the totality of evidence, unmet medical needs, study limitations and the evolvin